The World Health Organization (WHO) has published its first-ever report addressing the lack of medicines and diagnostic tools for invasive fungal diseases.
Dr Kristen Kroll from Washington University School of Medicine discusses new approaches for studying autism and other neurodevelopmental disorders by using human cellular models of brain development.
Black recipients of liver transplants have lower post-transplant survival rates than white or Hispanic patients, according to a new study from Keck Medicine of USC.
Dr Lynn Woods, Professor in the Department of Doctoral Programs, School of Nursing, Azusa Pacific University, explores behavioural symptoms of dementia in the Latinx population.
Professor Heather Sheardown from McMaster University provides detail about treating vision-related conditions, including injectable, in situ gelling systems.
Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.
Dr Faz Chowdhury, CEO at Nemaura Medical (Nasdaq: NMRD), aims to stem the tide of the onset of diabetes and help to manage and reverse Type 2 diabetes using the world’s first daily-wear non-invasive CGM technology.
Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.
